Other News To Note
Ikaria Inc., of Hampton, N.J., gained approval in Australia for Lucassin (terlipressin) in the treatment of hepatorenal syndrome (HRS) Type 1, a type of kidney failure, in patients with advanced liver cirrhosis who are being considered for a kidney transplant.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter